800 Participants Needed

Education on Lung Cancer Screening for Smokers

RJ
Overseen ByRobert J. Volk
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Educational Intervention, PRE-ACT Model, Patient Navigator Model for lung cancer screening?

Research shows that interventions focusing on education and patient navigation can help improve lung cancer screening rates, especially among racially and ethnically diverse groups. Patient navigation, which involves guiding patients through the healthcare system, has been shown to reduce barriers and increase participation in lung cancer screening.12345

Is the educational intervention for lung cancer screening safe for humans?

The educational intervention, including patient navigation and providing educational materials, has been used safely in studies to help people understand and participate in lung cancer screening. No safety concerns have been reported in these studies.56789

How does the education on lung cancer screening for smokers differ from other treatments for lung cancer?

This treatment is unique because it focuses on educating smokers about lung cancer screening, using patient navigation and community-based educational interventions to increase awareness and adherence to screening, rather than directly treating lung cancer itself. It aims to improve screening rates and reduce fear and worry about lung cancer, which is different from traditional treatments that focus on medical or surgical interventions for diagnosed cancer.1011121314

Research Team

RJ

Robert J. Volk

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

This trial is for English-speaking staff members of a quitline, aged between 55-80 years, who have smoked the equivalent of a pack a day for at least 30 years. It's also open to current smokers or those who've quit within the last 15 years. People with a history of lung cancer cannot participate.

Inclusion Criteria

I am over 18 and work for a quitline.
English-speaking
I am currently smoking or quit smoking less than 15 years ago.
See 2 more

Exclusion Criteria

I have been diagnosed with lung cancer.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Educational Intervention

Call center staff undergo a 60-minute educational session

1 week
1 session (in-person or virtual)

Referral and Questionnaire

Participants are referred to lung cancer screening educational materials and complete questionnaires

6 months
Questionnaires at 1 week and 6 months

Follow-up

Participants are monitored for effectiveness and reach of the educational intervention

Up to 4 years

Treatment Details

Interventions

  • Educational Intervention
Trial OverviewThe study is testing educational interventions and surveys to determine effective methods for informing heavy smokers about lung cancer screening options through tobacco quitlines.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Callers substudy (LCS educational materials, questionnaire)Experimental Treatment2 Interventions
Participants are referred to lung cancer screening educational materials. Participants also complete questionnaires at 1 week and 6 months after referral to educational materials.
Group II: Call center staff (educational intervention)Experimental Treatment2 Interventions
Participants undergo training consisting of a 60-minute educational session.

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

Lung cancer screening (LCS) is effective in reducing lung cancer mortality among high-risk smokers, but its adoption is limited, especially among racially and ethnically minoritized groups, highlighting a significant health disparity.
Interventions that streamlined the LCS process at clinics were found to be the most effective, while community-level efforts focused on education showed promise in engaging minoritized populations, indicating a need for more targeted research and standardized outcomes in future studies.
Interventions to improve lung cancer screening among racially and ethnically minoritized groups: A scoping review.Nam, J., Krishnan, G., Shofer, S., et al.[2023]
In a study of 901 high-risk patients undergoing CT lung cancer screening, 85.7% adhered to radiologist follow-up recommendations, indicating that high adherence rates are achievable in clinical settings.
The main reasons for nonadherence included patient refusal for follow-up exams (66.7%) and difficulties in contacting patients (20.9%), highlighting areas for improvement in patient engagement and communication.
Adherence to Radiology Recommendations in a Clinical CT Lung Screening Program.Alshora, S., McKee, BJ., Regis, SM., et al.[2018]
A single-page, paper-based encounter decision aid (EDA) used during shared decision-making visits for lung cancer screening significantly reduced patient decisional conflict, as indicated by a drop in the Decisional Conflict Scale score from 35.0 to 0.2 (p < 0.001).
While 28% of patients understood the mortality benefit of lung cancer screening after the visit, a much higher percentage (82%) grasped the frequency of abnormal screening results, highlighting the need for improved patient education on the mortality benefits of screening.
Pilot Study of an Encounter Decision Aid for Lung Cancer Screening.Ito Fukunaga, M., Balwan, A., Janis, JA., et al.[2023]

References

Interventions to improve lung cancer screening among racially and ethnically minoritized groups: A scoping review. [2023]
Adherence to Radiology Recommendations in a Clinical CT Lung Screening Program. [2018]
Pilot Study of an Encounter Decision Aid for Lung Cancer Screening. [2023]
An Analysis of Lung Cancer Screening Beliefs and Practice Patterns for Community Providers Compared to Academic Providers. [2023]
Assessing Barriers and Facilitators to Lung Cancer Screening: Initial Findings from a Patient Navigation Intervention. [2023]
Quantifying Benefits and Harms of Lung Cancer Screening in an Underserved Population: Results From a Prospective Study. [2023]
Provider and patient perspectives to improve lung cancer screening with low-dose computed tomography 5 years after Medicare coverage: a qualitative study. [2022]
Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers. [2023]
The tobacco quitline setting as a teachable moment: The Educating Quitline Users About Lung (EQUAL) cancer screening randomized trial. [2023]
Adapting Community Educational Programs During the COVID-19 Pandemic: Comparing the Feasibility and Efficacy of a Lung Cancer Screening Educational Intervention by Mode of Delivery. [2023]
Strategies to deliver smoking cessation interventions during targeted lung health screening - a systematic review and meta-analysis. [2023]
Risk perceptions among participants undergoing lung cancer screening: baseline results from the National Lung Screening Trial. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial. [2023]
14.United Statespubmed.ncbi.nlm.nih.gov
Patient navigation for lung cancer screening among current smokers in community health centers a randomized controlled trial. [2019]